首页 > 最新文献

You Should Leave Now最新文献

英文 中文
PHASE 3: 阶段3:
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.23
Sela Lounge
{"title":"PHASE 3:","authors":"Sela Lounge","doi":"10.2307/j.ctv1fj84w3.23","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.23","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"44 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127823515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE ELEMENTS OF RETREAT 撤退的要素
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.16
{"title":"THE ELEMENTS OF RETREAT","authors":"","doi":"10.2307/j.ctv1fj84w3.16","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.16","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130800382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GO YOUR OWN WAY 走自己的路
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.15
{"title":"GO YOUR OWN WAY","authors":"","doi":"10.2307/j.ctv1fj84w3.15","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.15","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"84 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"113975232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PHASE 8: 第八阶段:
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.28
{"title":"PHASE 8:","authors":"","doi":"10.2307/j.ctv1fj84w3.28","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.28","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124231085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
WHAT DOES (YOUR NAME HERE) WANT? (你的名字)有什么事?
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.17
{"title":"WHAT DOES (YOUR NAME HERE) WANT?","authors":"","doi":"10.2307/j.ctv1fj84w3.17","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.17","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129883593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PHASE 1: 阶段1:
Pub Date : 2021-07-13 DOI: 10.1201/9781439801550.sec1
B. Couple-Famille-Ménages
Background • Tumors attempt to evade the immune system by upregulating CD47, a marker of self. By blocking CD47 interaction with its myeloid cell receptor SIRPα, it may be possible to enhance innate and adaptive immunity against cancer.1 • ALX148 is a fusion protein comprised of an engineered high affinity CD47 binding domain of SIRPα genetically linked to an inactive Fc region of human immunoglobulin (Figure 1).2, 3 • In non clinical models, ALX148 blocks CD47 and safely enhances the activity of several anti-cancer targeted antibodies and checkpoint inhibitors through Fc dependent and independent mechanisms, bridging innate and adaptive anti-cancer immune response.2,3 • Based upon these observations, AT148001, a first-in-human phase 1 study of ALX148 administered as a single agent (Part 1) and in combination with established anticancer antibodies (Part 2) was initiated.
•肿瘤试图通过上调CD47(一种自我标记物)来逃避免疫系统。通过阻断CD47与其髓细胞受体SIRPα的相互作用,有可能增强对癌症的先天和适应性免疫。1•ALX148是一种融合蛋白,由SIRPα的高亲和力CD47结合域与人免疫球蛋白的失活Fc区基因连接组成(图1)。2,3•在非临床模型中,ALX148阻断CD47,并通过Fc依赖和独立机制安全地增强几种抗癌靶向抗体和检查点抑制剂的活性,架起先天和适应性抗癌免疫反应的桥梁。基于这些观察结果,AT148001,即ALX148作为单一药物(第一部分)和与已建立的抗癌抗体(第二部分)联合使用的首次人体i期研究开始了。
{"title":"PHASE 1:","authors":"B. Couple-Famille-Ménages","doi":"10.1201/9781439801550.sec1","DOIUrl":"https://doi.org/10.1201/9781439801550.sec1","url":null,"abstract":"Background • Tumors attempt to evade the immune system by upregulating CD47, a marker of self. By blocking CD47 interaction with its myeloid cell receptor SIRPα, it may be possible to enhance innate and adaptive immunity against cancer.1 • ALX148 is a fusion protein comprised of an engineered high affinity CD47 binding domain of SIRPα genetically linked to an inactive Fc region of human immunoglobulin (Figure 1).2, 3 • In non clinical models, ALX148 blocks CD47 and safely enhances the activity of several anti-cancer targeted antibodies and checkpoint inhibitors through Fc dependent and independent mechanisms, bridging innate and adaptive anti-cancer immune response.2,3 • Based upon these observations, AT148001, a first-in-human phase 1 study of ALX148 administered as a single agent (Part 1) and in combination with established anticancer antibodies (Part 2) was initiated.","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"150 12 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130877073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RETREAT, YOUR STYLE 撤退,你的风格
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.8
{"title":"RETREAT, YOUR STYLE","authors":"","doi":"10.2307/j.ctv1fj84w3.8","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.8","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116956319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ENERGETIC HEALTH 精力充沛的健康
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.10
{"title":"ENERGETIC HEALTH","authors":"","doi":"10.2307/j.ctv1fj84w3.10","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.10","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129185112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE FEMALE PREDICAMENT 女性的困境
Pub Date : 2021-07-13 DOI: 10.2307/j.ctv1fj84w3.7
{"title":"THE FEMALE PREDICAMENT","authors":"","doi":"10.2307/j.ctv1fj84w3.7","DOIUrl":"https://doi.org/10.2307/j.ctv1fj84w3.7","url":null,"abstract":"","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"81 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114600937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THIS MODERN LIFE 这种现代生活
Pub Date : 2021-07-13 DOI: 10.3138/9781442676619-023
生铁
“热门软件排行榜”总不如游戏软件排行榜那么好看,很长一段时间,我都把这归罪于软件厂商想象力的匮乏。比如IE5可起名字叫《星际争霸——网际探险》,IE6.0完全可以换个名字叫《魔兽争霸——英特纳之谜》。实际上应用软件能用就好,更何况还不断有新版本的出现来强大、完善其功能。完善的意思也就是更稳定、更方便和更高效率。你不会希望在老板要你半小时内尽快处理完一些文件时对他说:别急,我昨天又换了一套新软件,我要先练习一下。
“热门软件排行榜”总不如游戏软件排行榜那么好看,很长一段时间,我都把这归罪于软件厂商想象力的匮乏。比如IE5可起名字叫《星际争霸——网际探险》,IE6.0完全可以换个名字叫《魔兽争霸——英特纳之谜》。实际上应用软件能用就好,更何况还不断有新版本的出现来强大、完善其功能。完善的意思也就是更稳定、更方便和更高效率。你不会希望在老板要你半小时内尽快处理完一些文件时对他说:别急,我昨天又换了一套新软件,我要先练习一下。
{"title":"THIS MODERN LIFE","authors":"生铁","doi":"10.3138/9781442676619-023","DOIUrl":"https://doi.org/10.3138/9781442676619-023","url":null,"abstract":"“热门软件排行榜”总不如游戏软件排行榜那么好看,很长一段时间,我都把这归罪于软件厂商想象力的匮乏。比如IE5可起名字叫《星际争霸——网际探险》,IE6.0完全可以换个名字叫《魔兽争霸——英特纳之谜》。实际上应用软件能用就好,更何况还不断有新版本的出现来强大、完善其功能。完善的意思也就是更稳定、更方便和更高效率。你不会希望在老板要你半小时内尽快处理完一些文件时对他说:别急,我昨天又换了一套新软件,我要先练习一下。","PeriodicalId":399045,"journal":{"name":"You Should Leave Now","volume":"87 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114999509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
You Should Leave Now
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1